Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients
Recruiting
Observational Study
Stroke Acute
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- University of Aberdeen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can show changes in the brain within the first day of a stroke due to a blocked blood vessel or bleeding in the brain. The main question it aims to answer is:
• Can FCI identify brain tissue that might recover within the first few hours after a stroke begins?
Participants will undergo a standard M…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Acute stroke (\<24 hours from symptom onset).
* NIHSS ≥4 and \<25 with cortical involvement and/or large vessel occlusion on baseline imaging.
* Able to undergo 3T and FCI MRI \<24h of onset.
* With or without thrombolysis.
Exclusion Criteria:
* Contraindications to MRI.
* M…
Contacts